Galenika, a state-controlled firm established in 1945, was the first company in former Yugoslavia to be acquired by a foreign partner.
ICN Pharmaceuticals, which acquired a 75% stake in the drug maker under a 1990 agreement, planned to use it as a platform for growth in eastern Europe.
Serbia's government took over the Belgrade plant of ICN Pharmaceuticals in February 1999, after the commercial court in Belgrade ruled that ICN held a 35% stake and not 75%.
Galenika claimed a 25% share of the Serbian pharmaceuticals market in 2005, producing 36 out of the 100 best selling drugs in the country.
Serbia’s Privatisation Agency opened a privatisation tender for the company in December 2009 but it failed.
In June 2010, Galenika opened a EUR 50 million solid drugs plant in Zemun. A month later, the firm announced plans to open a representative office in Albania.
As of 2017, the company is represented in Montenegro, Bosnia i Herzegovina, Russia and Macedonia.
Headquarters
Batajnicki Drum bb
Belgrade; Belgrade;
Contact Details: Purchase the Galenika Ad Beograd report to view the information.
Website: http://www.galenika.co.rs
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service